Combined impact of inflammation, nutrition, and cardiovascular health on cancer survivor mortality: a retrospective NHANES cohort analysis (2005-2018).
설문조사
1/5 보강
[BACKGROUND] Inflammation, nutritional status, and cardiovascular health are all correlated withmortality in cancer survivors, yet their combined effect remains unclear.
- 95% CI 0.47-0.84
APA
Chen L, He Y, et al. (2025). Combined impact of inflammation, nutrition, and cardiovascular health on cancer survivor mortality: a retrospective NHANES cohort analysis (2005-2018).. Expert review of anticancer therapy, 25(12), 1459-1469. https://doi.org/10.1080/14737140.2025.2581140
MLA
Chen L, et al.. "Combined impact of inflammation, nutrition, and cardiovascular health on cancer survivor mortality: a retrospective NHANES cohort analysis (2005-2018).." Expert review of anticancer therapy, vol. 25, no. 12, 2025, pp. 1459-1469.
PMID
41146494 ↗
Abstract 한글 요약
[BACKGROUND] Inflammation, nutritional status, and cardiovascular health are all correlated withmortality in cancer survivors, yet their combined effect remains unclear.
[RESEARCH DESIGN AND METHODS] We included 2,322 cancer survivors from the National Health and Nutrition Examination Survey (NHANES) 2005-2018 cycles. The Advanced Lung Cancer Inflammation Index (ALI), reflecting inflammatory burden and nutritional status, and Life's Essential 8 (LE8), representing cardiovascular health, were categorized into tertiles and three-level groups, respectively. Survey-weighted multivariable Cox models estimated hazard ratios (HR) with 95% confidence intervals (CI).
[RESULTS] In multiple adjusted models, higher ALI was correlated with lower all-cause mortality (HR 0.63; 95% CI 0.47-0.84) and non-cancer mortality (HR 0.55; 95% CI 0.39-0.77). Similarly, elevated LE8 scores were linked to reduced risks of all-cause (HR 0.56; 95% CI 0.33-0.95) and non-cancer mortality (HR 0.39; 95% CI 0.22-0.67). Furthermore, high ALI was correlated with the lowest risk of all-cause mortality (HR, 0.38; 95% CI, 0.17-0.87) and non-cancer mortality (HR, 0.19; 95% CI, 0.06-0.56) death among cancer survivors who were high LE8 score.
[CONCLUSIONS] High ALI and LE8 together reduce all-cause and non-cancer mortality in cancer survivors, supporting combined nutritional-inflammatory and cardiovascular optimization for longer survival.
[RESEARCH DESIGN AND METHODS] We included 2,322 cancer survivors from the National Health and Nutrition Examination Survey (NHANES) 2005-2018 cycles. The Advanced Lung Cancer Inflammation Index (ALI), reflecting inflammatory burden and nutritional status, and Life's Essential 8 (LE8), representing cardiovascular health, were categorized into tertiles and three-level groups, respectively. Survey-weighted multivariable Cox models estimated hazard ratios (HR) with 95% confidence intervals (CI).
[RESULTS] In multiple adjusted models, higher ALI was correlated with lower all-cause mortality (HR 0.63; 95% CI 0.47-0.84) and non-cancer mortality (HR 0.55; 95% CI 0.39-0.77). Similarly, elevated LE8 scores were linked to reduced risks of all-cause (HR 0.56; 95% CI 0.33-0.95) and non-cancer mortality (HR 0.39; 95% CI 0.22-0.67). Furthermore, high ALI was correlated with the lowest risk of all-cause mortality (HR, 0.38; 95% CI, 0.17-0.87) and non-cancer mortality (HR, 0.19; 95% CI, 0.06-0.56) death among cancer survivors who were high LE8 score.
[CONCLUSIONS] High ALI and LE8 together reduce all-cause and non-cancer mortality in cancer survivors, supporting combined nutritional-inflammatory and cardiovascular optimization for longer survival.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Inflammation
- Female
- Male
- Cancer Survivors
- Nutrition Surveys
- Middle Aged
- Retrospective Studies
- Nutritional Status
- Cardiovascular Diseases
- Aged
- Neoplasms
- Adult
- Cohort Studies
- Proportional Hazards Models
- Lung Neoplasms
- Advanced lung cancer inflammatory index (ALI)
- Cancer survivors
- Life’s Essential 8 (LE8)
- Mortality
- National Health and Nutrition Examination Survey (NHANES)
같은 제1저자의 인용 많은 논문 (5)
- Comparison of Artecoll, Restylane and silicone for augmentation rhinoplasty in 378 Chinese patients.
- Analyzed PD-L1-positive subpopulations by dual-labeling TSA-IF-FISH predicts immunotherapy efficacy in advanced lung cancer.
- The Prognostic and Biological Value of PGF-Based H&E Pathomics in Hepatocellular Carcinoma.
- Enhanced Understanding of Procalcitonin Utilization as an Infection Biomarker in Non-Hodgkin's Lymphoma.
- NK cell biomimetic MOF nanoplatform disrupts hypoxia adaption for complete tumor ablation.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.